Antidiabetic Effect of Fermented (Millet) Supplement in Alloxan Induced Hyperglycemic Wistar Rats
Antidiabetic Effect of Fermented (Millet) Supplement in Alloxan Induced Hyperglycemic Wistar Rats
Antidiabetic Effect of Fermented (Millet) Supplement in Alloxan Induced Hyperglycemic Wistar Rats
http://dx.doi.org/10.4314/bajopas.v9i1.21
138
Bajopas Volume 9 Number 1 June, 2016
It has been recommended for several therapeutic pellets grower mash only , Group II (diabetic control)-
purposes, as it has been found to inhibit tumor Alloxan induced hyperglycemic wistar rats +normal
development (Lee, 2010), control blood pressure and saline (0.2ml) orally fed with, Group III- Alloxan
plasma low density lipoprotein cholesterol levels induced hypeglycemic wistar rats + 33% millet
(Hosoda, 2012), and possesses anti-allergenic supplement (Goodarzi, et al., 2011), Group IV-
characteristics. Alloxan induced hyperglycemic wistar rats + 66%
The aim of the study was to evaluate the effect of the millet supplement (Goodarzi, et al., 2011), Group V-
Pennisetum Glaucum supplement on blood glucose Alloxan induced hyperglycemic wistar rats +
level and lipid profile in alloxan induced hyperglycemic glibenclamide (5mg/kg) orally
wistar rats. Blood Glucose Determination
Fasting blood glucose levels was determined at day 0,
MATERIALS AND METHODS 4, 8, 12 and 14 respectively for 2weeks using the
Experimental Animals glucose oxidase principle (Beach and Turner, 1958)
A total of 25 wistar rats of both sexes weighing 160g- using one touch digital glucometer
200g were purchased at the experimental animal Sample Collection
house of the Department of Human Physiology, At the end of the experiment, after overnight fasting,
Ahmadu Bello University Zaria. Animals were the animals were anaesthesized using chloroform and
maintained under normal laboratory conditions. The dissected, blood was collected through cardiac
animals were fed on pellets of growers mash and puncture, centrifuged and serum was used for
allowed access to water ad libitum. The study was assessment of lipid profile.
conducted in accordance with the guidelines of Lipid Profile Assay
Ahmadu Bello University in accordance with the rules The method of Roeschlau and Gruber was applied
governing the use of laboratory animals as accepted using assay kits (Randox Laboratories Ltd., UK) to
internationally (National Institute of Health Guide for determine the total serum cholesterol
Care and Use of Laboratory Animals) spectrophotometrically at 546 nm following enzymatic
Collection, Identification and Preparation of hydrolysis and oxidation (Allain et al., 1974). The
Supplement HDL-cholesterol was determined using assay kits
Pennisetum Glaucum was purchased from Institute of (Randox Laboratories Ltd., UK) after low density
Agricultural Research Zaria, Kaduna State of Northern lipoprotein (LDL and VLDL) and chylomicron fractions
Nigeria. It was identified at the Herbarium unit of the were precipitated quantitatively by the addition of
department of Biological Sciences, Ahmadu Bello phosphotungstic acid in the presence of magnesium
University, Zaria and a specimen voucher with the ions. After centrifugation, the cholesterol
number 27111 was deposited. Three (3) kg of the concentration in the HDL fraction in the supernatant
pearl millet (Pennisetum Glaucum ) was soaked in was assayed colorimetrically at 540 nm (Allain et al.,
water for 72 hours. Thereafter, it was air dried under 1974).
the sun for seven days. Later it was grounded to Statistical Analysis
powder using grinding machine. Data collected were expressed as mean + SEM. They
Drugs Used were analyzed by one way analysis of variance,
Alloxan was purchased from (Sigma chemical ANOVA, and Tukey’s post-hoc test was used to
company St. Louis U.S.A), glibenclamide and all other compare the level of significance between the control
chemicals and reagents that were used were of and treatment groups, using SPSS version 20.0.
analytical grade. Values of p<0.05 were considered significant.
Induction of Diabetes Mellitus
After 16-18 hours of fasting, hyperglycemia was RESULTS
induced by a single intraperitoneal injection of alloxan Effect of Pennisetum Glaucum (PG) supplement
monohydrate ( Sigma St. Louis, M.S., U.S.A.) at a on blood glucose level: The results of the present
dose of 150mg/kg body weight (dissolved in 0.9% study showed that blood plasma glucose level in the
NaCl cold normal saline solution) ( Katsumata et al., diabetic control group was significantly
1999). Rats were treated with 20% glucose solution higher(p<0.05) when compared with the normal
orally for 6hrs due to the ability of alloxan to produce control group in the entire 16 days of the study. The
fatal hypoglycemia as a result of massive pancreatic effect of P.G. on blood plasma glucose level was
insulin release. They were placed on 5% glucose determined by comparing the values in the diabetic
solution for 24 hrs to prevent hypoglycemia control group (i.e. Group 2) with the values in Group
(Dhandapani et al., 2002). Blood was collected from 4 (i.e. 33% P.G.) and in Group 5 (i.e. 66% P.G.).
the tail vein of the rats after 72hrs of alloxan These results showed that P.G. supplement was
injection. Rats having fasting blood glucose level lowered the blood Glucose Level (p<0.05) within
greater than 200mg/dl were selected for the study sixteen days of its administration dose dependently on
(Matteucci and Giampietro, 2008). Day 12 and 16 respectively, when compared with the
Experimental Design and Treatment Diabetic Control. Its effect appeared to be even more
Wistar rats were weighed and randomly assigned into potent and significant than that of the standard drug
5 groups, with 5 animals (n=5), in each. Group 1 glibenclamide (Table 1)
(normal control) - Normogycemic wistar rats fed with
139
Bajopas Volume 9 Number 1 June, 2016
Table 1: Effect of Sixteen Days Administration of Pennisetum glaucum (PG) Supplement on Blood
Glucose Levels (mg/dl) in Alloxan Induced Hyperglycemic Wistar Rats
Group/Treatment Day 0 Day 4 Day 8 Day 12 Day 16
Normal control 68.00 ± 6.25 50.40 ± 2.75 70.60 ± 7.09 63.80 ± 3.87 70.40 ± 3.54
Diabetic control 430.60 ± 56.14 414.60 ± 80.37 326.40 ± 31.04 324.20 ± 23.06 292.40 ± 25.13
33% PG 434.60 ± 53.22 456.80 ± 88.31 315.20 ± 58.20 253.00 ± 70.79 128.80 ± 34.50*
66%PG 434.20 ± 69.98 418.00 ± 74.35 246.40 ± 50.70 143.60 ± 26.26* 106.40 ± 15.48*
Glibenclimide 430.00 ± 74.65 332.40 ± 72.29 181.80 ± 38.94 120.20 ± 27.43* 85.40 ± 19.03*
Group 1: Normoglycemic Rats; Group 2: Hyperglycemic Rats (Diabetic Control); Group 3: Diabetic Rats +
2mg/kg Glibenclamide (Positive Control); Group 4: Diabetic Rats Treated with 33% of P.G. Supplement; Group 5:
Diabetic Rats Treated with 66% of P.G. Supplement.
* Statistically Significant at p< 0.05 when compared with Untreated Diabetic Control
Effect of Pennisetum Glaucum Supplement on glibenclamide. It also showed that P.G. at both 33%
Serum Lipid Profile: These results of the present and 66% supplement lowered the Triglycerides and
study revealed that P.G. at 33% and 66% supplement LDL serum levels( p<0.05) as well increase HDL
was able to lower cholesterol levels dose dependently serum levels although not statistically significant
and significantly when compared to the diabetic (Table 2).
untreated group more than the standard drug
Table 2: Effect of Sixteen Days Administration of Pennisetum glaucum (PG) Supplement on Lipid
Profile in Alloxan Induced hyperglycemic Wistar Rats
Group/Treatment Total Cholesterol(mmol/L) Triglycerides(mmol/L) HDL(mmol/L) LDL(mmol/L)
Normal control 1.16 ± 0.10 1.11 ± 0.10 0.51 ± 0.09 0.14 ± 0.04
Diabetic control 2.64 ± 0.08 1.42 ± 0.12 0.33 ± 0.07 1.46 ± 0.14
33% PG 1.72 ± 0.26 0.81 ± 0.01 1.85 ± 0.81 0.10 ± 0.99
66%PG 1.60 ± 0.35* 1.39 ± 0.14 0.60 ± 0.21 0.43 ± 0.26
Glibenclimide 1.43 ± 0.25* 1.21 ± 0.25 0.65 ± 0.14 0.23 ± 0.08
Group 1: Normoglycemic Rats; Group 2: Hyperglycemic Rats (Diabetic Control); Group 3: Diabetic Rats +
2mg/kg Glibenclamide (Positive Control); Group 4: Diabetic Rats Treated with 33% of P.G. Supplement; Group 5:
Diabetic Rats Treated with 66% of P.G. Supplement.
* Statistically Significant at p< 0.05 when compared with Untreated Diabetic Control
These indicate that millet and sorghum can be well- cholesterol lowering effect of P.G. may be due to the
utilized to produce broiler chickens with superior carcass availability of flavonoids in it, Flavonoids as antioxidants
quality compared to maize. Nishizara also showed that may inhibit the oxidation of LDL cholesterol (prevention
dietry Japanese millet protein ameliorated plasma levels of atherosclerotic plaque formation) (Middleton, et al.,
of lipids in type 2 diabetic mice and also increased the 2000; Duarte-Alameida, et al., 2007).
levels of high density lipoprotein (Nishizara, 2009). CONCLUSION
The ability of P.G. supplement to reduce plasma The study confirmed the association between of
cholesterol and triglycerides in diabetic animals could be hyperglycemia and abnormal lipid profile. Administration
explained by its reported high content of magnesium. of Pennisetum glaucum supplement at different
Magnesium helps to improve the ability of cells to percentages lowered blood glucose level which was even
respond to insulin, by increasing the levels of adiponectin more effective than the standard drug glibenclamide.
hormone. Adiponectin is produced in fat tissues, which is Pennisetum glaucum lower the cholesterol levels more
a beneficial hormone that helps in energy metabolism, it than the standard drug glibenclamide. Its lower
helps cells burn fats for energy and improve triglyceride levels, increased serum HDL levels although
cardiovascular health (Nishizara, 2009). Since insulin is not statistically significant, but significantly restored
required for the inhibition of hormone-sensitive lipase HDL/Cholesterol and Triglycerides/HDL ratios to normal
and hence increases the utilization of glucose and physiological range. Hence, it can be concluded that
thereby decreasing the mobilization of free fatty acids supplementation with Pennisetum Glaucum has high
from the fat depots. The decreased level of FFA is also hypoglycemic effect and also hypolipidemic property in
associated with decreased actions of lipolytic hormones, alloxan induced hyperglycemic wistar rats.
which, in turn, decreased the activity of hormone
sensitive lipases on fat deposits (Daniel et al., 2015). The